Skip to main content
. Author manuscript; available in PMC: 2018 Dec 15.
Published in final edited form as: Mucosal Immunol. 2018 Jun 15;11(5):1375–1385. doi: 10.1038/s41385-018-0048-x

Table I.

Patient Demographics

A. Plasma Samples

Control (n = 7) CRSwNP (n = 18) p Value
Sex, no. (%) 0.9428
Men 3 (42.9) 8 (44.4)
Women 4 (57.1) 10 (55.6)
Age, mean ± SD 47.4 ± 23.6 40.2 ± 18.5 0.1629
Race, no. (%) 0.4090
White 3 (42.9) 11 (61.1)
African American 4 (57.1) 7 (38.9)
Other 0 (0) 0 (0)
SNOT22 Score, mean ± SD 49.3 ± 27.8 [14]

B. Nasal Mucus Samples

Control (n = 6) CRSwNP (n = 11) p Value

Sex, no. (%) 0.7933
Men 4 (66.7) 8 (72.72)
Women 2 (33.3) 3 (27.3)
Age, mean ± SD 35.5 ± 14.5 42.45 ± 21.92 0.4985
Race, no. (%) 0.6905
White 4 (66.7) 7 (63.64)
African American 2 (33.3) 3 (27.27)
Other 0 (0) 1 (9.1)
SNOT22 Score, mean ± SD 49.625 ± 20.27 [8]

SNOT22 = sinonasal outcome test-22. SD = standard deviation. [n] = number of patients with available SNOT22 scores.